Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma

Human hepatocellular carcinoma (HCC) has a high rate of tumor recurrence and metastasis, resulting in shortened survival times. The efficacy of current systemic therapies for HCC is limited. In this study, we used xenograft tumor models to investigate the use of antibodies that block CD47 and inhibi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Lett
Main Authors: Xiao, Zhenyu, Chung, Haniee, Banan, Babak, Manning, Pamela T., Ott, Katherine C., Lin, Shin, Capoccia, Benjamin J., Subramanian, Vijay, Hiebsch, Ronald R., Upadhya, Gundumi A., Mohanakumar, Thalachallour, Frazier, William A., Lin, Yiing, Chapman, William C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886734/
https://ncbi.nlm.nih.gov/pubmed/25721088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2015.02.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados